LEONARDIS, DANIELA
 Distribuzione geografica
Continente #
AS - Asia 1.914
NA - Nord America 817
SA - Sud America 380
EU - Europa 378
AF - Africa 32
OC - Oceania 6
Totale 3.527
Nazione #
SG - Singapore 868
US - Stati Uniti d'America 777
CN - Cina 436
BR - Brasile 306
VN - Vietnam 206
HK - Hong Kong 172
FR - Francia 121
IT - Italia 105
KR - Corea 69
IN - India 34
JP - Giappone 29
DE - Germania 27
AR - Argentina 26
GB - Regno Unito 26
BD - Bangladesh 22
NL - Olanda 21
CA - Canada 17
FI - Finlandia 17
IL - Israele 12
CO - Colombia 11
EC - Ecuador 10
MX - Messico 10
ID - Indonesia 9
RU - Federazione Russa 9
UA - Ucraina 7
UY - Uruguay 7
UZ - Uzbekistan 7
VE - Venezuela 7
IQ - Iraq 6
SA - Arabia Saudita 6
TR - Turchia 6
ZA - Sudafrica 6
ES - Italia 5
PE - Perù 5
AT - Austria 4
AU - Australia 4
EG - Egitto 4
IE - Irlanda 4
KZ - Kazakistan 4
MA - Marocco 4
PL - Polonia 4
PY - Paraguay 4
SE - Svezia 4
TN - Tunisia 4
TT - Trinidad e Tobago 4
AL - Albania 3
CL - Cile 3
CR - Costa Rica 3
CZ - Repubblica Ceca 3
DZ - Algeria 3
KE - Kenya 3
LK - Sri Lanka 3
NP - Nepal 3
TH - Thailandia 3
AE - Emirati Arabi Uniti 2
AZ - Azerbaigian 2
CI - Costa d'Avorio 2
EE - Estonia 2
HU - Ungheria 2
JO - Giordania 2
KG - Kirghizistan 2
LT - Lituania 2
MT - Malta 2
NZ - Nuova Zelanda 2
PA - Panama 2
PH - Filippine 2
PK - Pakistan 2
SI - Slovenia 2
AF - Afghanistan, Repubblica islamica di 1
AG - Antigua e Barbuda 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BF - Burkina Faso 1
BO - Bolivia 1
BY - Bielorussia 1
CH - Svizzera 1
ET - Etiopia 1
GA - Gabon 1
GE - Georgia 1
GR - Grecia 1
LB - Libano 1
LV - Lettonia 1
MD - Moldavia 1
MY - Malesia 1
NG - Nigeria 1
NI - Nicaragua 1
OM - Oman 1
PR - Porto Rico 1
PT - Portogallo 1
RO - Romania 1
SN - Senegal 1
SO - Somalia 1
TM - Turkmenistan 1
TW - Taiwan 1
Totale 3.527
Città #
Singapore 550
Santa Clara 277
Hong Kong 171
Hefei 159
Beijing 111
Lauterbourg 98
San Jose 86
Ho Chi Minh City 84
Seoul 69
Ashburn 57
Los Angeles 53
Hanoi 49
New York 35
Dallas 23
São Paulo 21
Buffalo 17
Tokyo 17
Rio de Janeiro 16
Frankfurt am Main 12
Haiphong 10
Minamishinagawa 10
Bari 9
Helsinki 9
Amsterdam 7
Bengaluru 7
Brasília 7
Curitiba 7
Belo Horizonte 6
Da Nang 6
Montevideo 6
Rome 6
Salvador 6
Guangzhou 5
Guayaquil 5
Hải Dương 5
Londrina 5
Milan 5
Munich 5
Newark 5
Orem 5
Portsmouth 5
Tashkent 5
Biên Hòa 4
Catania 4
Chennai 4
Dublin 4
Ha Long 4
Lappeenranta 4
London 4
Porto Alegre 4
Sheffield 4
Stockholm 4
Turku 4
Bangkok 3
Bắc Ninh 3
Camaçari 3
Campinas 3
Can Tho 3
Colombo 3
Contagem 3
Elk Grove Village 3
Florence 3
Guarulhos 3
Hyderabad 3
Lima 3
Nairobi 3
Naples 3
New Delhi 3
Phoenix 3
Quận Chín 3
San José 3
Sete Lagoas 3
Sorocaba 3
Sydney 3
Toronto 3
Warsaw 3
Abidjan 2
Almaty 2
Amman 2
At Tuwal 2
Atlanta 2
Avellaneda 2
Baghdad 2
Baku 2
Baturité 2
Belém 2
Bishkek 2
Brooklyn 2
Cabo Frio 2
Cagliari 2
Cairo 2
Campo Grande 2
Campos dos Goytacazes 2
Canoas 2
Cariacica 2
Caxias do Sul 2
Chengdu 2
Chicago 2
City of London 2
Cotia 2
Totale 2.212
Nome #
Distance from the outbreak of infection, ozone pollution and public health consequences of SARS-CoV-2 epidemic: the HOPE method 89
Epidemiology of hyperkalemia in CKD patients under nephrological care: a longitudinal study 78
Methods to Analyze Time-to-Event Data: The Cox Regression Analysis 72
Neuropeptide y gene polymorphisms and chronic kidney disease progression 72
Office, standardized and 24-h ambulatory blood pressure and renal function loss in renal transplant patients 68
A polymorphism in the major gene regulating serum uric acid associates with clinic SBP and the white-coat effect in a family-based study 66
Fundamentals and Applications of the Receiver Operating Characteristic Curve Analysis in the Research of Endothelial Dysfunction in Chronic Kidney Disease 66
Verso un sistema di qualità: presentazione delle nuove linee guida della regione Calabria per l'inserimento ed il mantenimento in lista d'attesa per trapianto di rene. 63
Phosphate and the renoprotective effect of ace inhibition: a post-hoc analysis of the Rein Trial. 60
ROC curve analysis: a useful statistic multi-tool in the research of nephrology 57
Are there sex differences in cardiovascular outcomes in non-dialysis CKD patients? 57
Venous bicarbonate and CKD progression: a longitudinal analysis by the group-based trajectory model 56
Creatinine calibration and CKD staging 55
A Genetic Marker of Uric Acid Level, Carotid Atherosclerosis, and Arterial Stiffness: A Family-Based Study 55
Competitive interaction between fibroblast growth factor 23 and asymmetric dimethylarginine in patients with CKD. 55
Sleep Disordered Breathing in Renal Transplant Patients. 53
CKD-MBD biomarkers and CKD progression: an analysis by the joint model 52
Valore prognostico delle formule di dtims del FG nella popolazione di pazienti con MRC dello studio MAURO. 50
Nocturnal Hypertension and Altered Night-Day BP Profile and Atherosclerosis in Renal Transplant Patients 50
Methods to Analyse Time-to-Event Data: The Kaplan-Meier Survival Curve 50
Association of IL-6 and a functional polymorphism in the IL-6 gene with cardiovascular events in patients with CKD 50
Synergism between asymmetric dimethylarginine (ADMA) and a genetic marker of uric acid in CKD progression 47
Simple Statistical Measures for Assessing the Accuracy of a Diagnostic Test in Clinical Medicine 47
Serum Erythroferrone Levels Associate with Mortality and Cardiovascular Events in Hemodialysis and in CKD Patients: A Two Cohorts Study 47
A polymorphismin a major antioxidant gene (Kelch-like ECH-associated protein1) predicts incident cardiovascular events in chronic kidney disease patients: an exploratory study 47
Inflammation downregulates FGF23 in chronic kidney disease (CKD) patients. 46
Different rates of progression and mortality in patients with chronic kidney disease at outpatient nephrology clinics across Europe 44
Circulating E-selectin as a risk marker in patients with end-stage renal disease 43
Differences between GFR estimation by an equation based on creatinine and one based on Cystatine C 43
Neuropeptide Y and chronic kidney disease progression: a cohort study 41
Plasma cytokines, glomerular filtration rate and adipose tissue cytokines gene expression in chronic kidney disease (CKD) patients. 40
Semeiotica della pressione arteriosa 39
Association of a polymorphism in a gene encoding a urate transporter with ckd progression 36
Circulating soluble receptor for advanced glycation end product (sRAGE) and left ventricular hypertrophy in patients with chronic kidney disease (CKD) 36
Il sistema metabolico che regola l'ADMA è presente negli adipociti umani ed è iperespresso nell'insufficienza renale. 33
Epidemiology of CKD Regression in Patients under Nephrology Care 33
La E-selettina è un marker di rischio e interagisce con la flogosi nei pazienti in dialisi. 31
High estimated pulmonary artery systolic pressure predicts adverse cardiovascular outcomes in stage 2-4 chronic kidney disease 31
Functional correlates and gene expression in fat cells of visfatin/pre-b cell enhancing factor in ckd patients. 30
FGF23 beyond bone mineral metabolism: functional relationship with inflammation in chronic kidney disease patients. 30
The fat-mass and obesity-associated gene (FTO) predicts mortality in chronic kidney disease of various severity 30
Long-term visit-to-visit office blood pressure variability increases the risk of adverse cardiovascular outcomes in patients with chronic kidney disease 29
Insufficienza renale, ipertensione arteriosa e fattori di rischio cardiovascolare. L'ipertensione arteriosa. Il contributo della ricerca italiana edizione 2007. 28
Il sistema metabolico che regola l'ADMA è presente negli adipociti umani ed è iperespresso nell'insufficienza renale. 27
Infiammazione sistemica ed espressione genica nel tessuto adiposo sottocutaneo delle citochine infiammatorie nei pazienti con insufficienza renale cronica. 27
Osteoprotegerin abd carotid atherosclerosis in uremic patients: an imaging (eco-doppler) and genic expression study 27
Creatinine standardization and CKD staging. 27
Inflammation downregulates FGF23 in chronic kidney disease (CKD) patients. 27
Osteoprotegerina ed aterosclerosi carotidea nei pazienti in dialisi: uno studio di imaging (eco-doppler) e di espressione genica. 26
Salt intake and inflammation in essential hypertension. 26
Obesity, disease progression and Ramipril renoprotective effects in proteinuric chronic nephropathy: a post-hoc analyses of the REIN Study. 26
Searching for biomarker patterns characterizing carotid atherosclerotic burden in patients with reduced renal function 26
Circulating soluble receptor of advanced glycation end product inversely correlates with atherosclerosis in patients with chronic kidney disease 26
Revisione delle linee guida regionali per l inserimento e il mantenimento in lista d attesa per trapianto di rene dei pazienti con insufficienza renale cronica in trattamento sostitutivo (Calabria) 25
Soluble E-selectin is inversely related to cardiac wall thickness in patients with end stage renal disease (ESRD). 25
Stimare il filtrato glomerulare: calibrazione e formule 25
La sleep apnea ha un'alta prevalenza nell'insufficienza renale cronica di grado moderato severo ed è fortemente associata all'ipertensione notturna e all'aterosclerosi carotidea. 24
Circulating soluble RAGE in patients with chronic kidney disease as an inverse correlate of atherosclerosis. 24
Asymmetric Dimethylarginine (ADMA) Enzymatic Machinery and Adipokines Gene Expression in the Adipose Tissue in Stage 3-5 CKD patients. 24
Serum phosphate within the normal range predicts the risk of CKD progression. 24
The full ADMA machinery is expressed in human adipocytes: differential regulation in healthy and uremic man. 24
ADMA machinery is expressed in adipocytes in humans and it is differentially regulated in CKD and ESRD patients 24
Insulin Sensitivity, Systemic Inflammation and Adipose Tissue Gene Expression of Inflammatory Cytokines in Chronic Kidney Disease (CKD) and in Obese Patients. 23
Differences between GFR estimation by a creatinine based equation and one cystatin C based. 23
La riduzione dell'intake di sale influenza l'infiammazione nell'ipertensione arteriosa essenziale? 23
Audit sui principali indicatori di procurement e di efficienza del processo di donazione in Calabria. 23
Malattie infettive e Trapianti 23
Soluble E-selectin is inversely related to cardiac wall thickness in patients with end stage renal disease . 23
Role of Obesity and Metabolic Alterations in Hypertensive Renal Disease and in Chronic Kidney Disease 23
The full ADMA machinery is expressed in human adipocytes: differential regulation in healthy and uremic man. 23
La frequenza della sleep apnea nei trapiantati di rene non differisce da quella della popolazione generale. 23
La fosforemia è un predittore indipendente di progressione della malattia renale cronica? 23
The prevalence of Sleep Disordered Breathing in Renal Transplant Patients Does Not Differ from that in the general population. 23
Osteoprotegerin and carotid atherosclerosis in dialysis patients: an imaging (Eco-doppler) and genic expression study. 23
The metabolic syndrome and chronic kidney disease epidemics: severing the link? 22
Audit clinico sulle principali aree di intervento della malattia renale cronica: verifica obiettivi linee guida su un campione rappresentativo della popolazione dello studio che ha concluso il periodo di osservazione. 22
Are derived equations to estimate Glomerular Filtration Rate (GFR) in Chronic Kidney Disease ( CKD) patients different in their prognostic value? 22
Insulin Sensitivity, Systemic Inflammation and Adipose Tissue Gene Expression of Inflammatory Cytokines in Chronic Kidney Disease (CKD) and in Obese Patients. 22
Beyond bone mineral metabolism: functional relationship with inflammation in chronic kidney disease (CKD) patients. 22
Functional correlates and gene expression in fat cells of visfatin/pre-b cell enhancing factor in CKD patients. 22
Searching for Biomarker Patterns Characterizing Carotid Atherosclerotic Burden (AB) in Patients with Reduced Renal Function. 22
Serum phosphate within the normal range predicts the risk of CKD progression 22
Renal transplant patients have no excess risk for sleep apnoea. 22
Metodi di stima del filtrato glomerulare, rischio di progressione della malattia renale e del rischio cardiovascolare nei pazienti con insufficienza renale cronica (IRC). 21
Renal transplant patients have no excess risk for sleep apnoea. 21
La riduzione dell'intake di sale influenza l'infiammazione nell'ipertensione arteriosa essenziale? 21
I livelli circolanti di selettina-E sono inversamente correlati allo spessore delle pareti del ventricolo sinistro nei pazienti dializzati. 21
Soluble e-selectin is an inverse and independent predictor of left ventricular wall thickness in end-stage renal disease patients. 21
Serum phosphate within the normal range predicts the risk of CKD progression. 21
Valore prognostico delle formule di stima del filtrato glomerulare in pazienti con malattia renale cronica. 21
Sleep apnea (SA) is prevalent in chronic kidney disease (CKD) and entails a high cardiovascular risk. 20
Blood-pressure control for renoprotection in patients with non-diabetic chronic renal disease (REIN-2): multicentre, randomised controlled trial. 20
Osteoprotegerin and carotid atherosclerosis in dialysis patients: an imaging (Eco-doppler) and genic expression study. 20
Systemic and adipose tissue inflammation in chronic kidney disease (CKD) patients. 20
Methylarginine enzymatic machinery and Leptin in adipose tissue in CKD patients. 20
Circulating soluble RAGE in patients with chronic kidney disease as an inverse correlate of atherosclerosis. 20
Valore prognostico delle formule di stima del FG nella popolazione di pazienti con MRC dello studio MAURO. 20
Soluble E-Selectin Is an Inverse and Independent Predictor of Left Ventricular Wall Thickness in End-Stage Renal Disease Patients. 19
The prevalence of sleep disordered breathing in renal transplant patients does not differ from that in the general population. 19
La riduzione dell'intake di sale influenza l'infiammazione nell'ipertensione arteriosa essenziale? 19
Totale 3.407
Categoria #
all - tutte 12.044
article - articoli 5.842
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 271
Totale 18.157


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/202431 0 0 0 0 0 0 0 0 24 0 7 0
2024/20251.454 12 3 133 90 305 12 28 58 48 43 395 327
2025/20262.124 121 220 203 306 400 63 346 134 109 133 89 0
Totale 3.609